טוען...
Praziquantel Synergistically Enhances Paclitaxel Efficacy to Inhibit Cancer Cell Growth
The major challenges we are facing in cancer therapy with paclitaxel (PTX) are the drug resistance and severe side effects. Massive efforts have been made to overcome these clinical challenges by combining PTX with other drugs. In this study, we reported the first preclinical data that praziquantel...
שמור ב:
| Main Authors: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Public Library of Science
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3520897/ https://ncbi.nlm.nih.gov/pubmed/23251610 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0051721 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|